Your browser doesn't support javascript.
loading
A genome-wide analysis of the response to inhaled ß2-agonists in chronic obstructive pulmonary disease.
Hardin, M; Cho, M H; McDonald, M-L; Wan, E; Lomas, D A; Coxson, H O; MacNee, W; Vestbo, J; Yates, J C; Agusti, A; Calverley, P M A; Celli, B; Crim, C; Rennard, S; Wouters, E; Bakke, P; Bhatt, S P; Kim, V; Ramsdell, J; Regan, E A; Make, B J; Hokanson, J E; Crapo, J D; Beaty, T H; Hersh, C P.
Affiliation
  • Hardin M; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Cho MH; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • McDonald ML; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Wan E; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Lomas DA; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Coxson HO; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • MacNee W; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Vestbo J; Wolfson Institute for Biomedical Research, University College London, London, UK.
  • Yates JC; UBC Department of Radiology, Vancouver General Hospital, Vancouver, Canada.
  • Agusti A; Centre for Inflammation Research, University of Edinburgh, Edinburgh, Scotland, UK.
  • Calverley PM; Department of Respiratory Medicine, Manchester Academic Health Sciences Centre, University Hospital of South Manchester, Manchester, UK.
  • Celli B; GlaxoSmithKline, Research Triangle Park, NC, USA.
  • Crim C; Thorax Institute, Hospital Clinic, IDIBAPS, Univ Barcelona and CIBERES, Barcelona, Spain.
  • Rennard S; Department of Pulmonary and Rehabilitation Medicine, University of Liverpool, Liverpool, UK.
  • Wouters E; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Bakke P; GlaxoSmithKline, Research Triangle Park, NC, USA.
  • Bhatt SP; Pulmonary and Critical Care Division, Department of Medicine, University of Nebraska, Omaha, NE, USA.
  • Kim V; Center for Chronic Diseases, University Hospital Maastricht, Maastricht, The Netherlands.
  • Ramsdell J; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Regan EA; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama, Birmingham, AL, USA.
  • Make BJ; Division of Pulmonary and Critical Care, Temple University Hospital, Philadelphia, PA, USA.
  • Hokanson JE; University of California, San Diego, San Diego, CA, USA.
  • Crapo JD; Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Health, Denver, CO, USA.
  • Beaty TH; Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Health, Denver, CO, USA.
  • Hersh CP; Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Denver, CO, USA.
Pharmacogenomics J ; 16(4): 326-35, 2016 08.
Article in En | MEDLINE | ID: mdl-26503814

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchodilator Agents / Pulmonary Disease, Chronic Obstructive / Adrenergic beta-2 Receptor Agonists / Pharmacogenomic Variants / Lung Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte / Europa / Oceania Language: En Journal: Pharmacogenomics J Journal subject: BIOLOGIA MOLECULAR / FARMACOLOGIA Year: 2016 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchodilator Agents / Pulmonary Disease, Chronic Obstructive / Adrenergic beta-2 Receptor Agonists / Pharmacogenomic Variants / Lung Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte / Europa / Oceania Language: En Journal: Pharmacogenomics J Journal subject: BIOLOGIA MOLECULAR / FARMACOLOGIA Year: 2016 Document type: Article Affiliation country: United States Country of publication: United States